Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425004
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1425004
Bladder Cancer Therapeutics and Diagnostics Market, By Diagnostic, By Cancer Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
PUBLISHED:
PAGES: 289 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
Bladder Cancer Therapeutics and Diagnostics Market size was valued at USD 3,794.2 Million in 2022, expanding at a CAGR of 5.7% from 2023 to 2030.
Acute lymphocytic/lymphoblastic leukemia is a cancer type originating from immature lymphocytes. The term "acute" denotes its rapid progression and spread throughout the body, originating in the bone marrow and swiftly infiltrating other vital organs like the liver, spleen, lymph nodes, central nervous system, and bloodstream. Symptoms may include fatigue, pallor, easy bruising, gum and nosebleeds, weight loss, shortness of breath, and loss of appetite. Multiple therapeutic approaches, including chemotherapy, are utilized in ALL treatment.
Bladder Cancer Therapeutics and Diagnostics Market- Market Dynamics
Increasing awareness of bladder diseases and available therapies, expanding healthcare expenditure, and the mounting burden of bladder cancer is expected to propel the market demand
The bladder cancer therapeutics and diagnostics market is poised for rapid growth, fueled by factors such as increasing awareness of bladder diseases and available therapies, expanding healthcare expenditure, and the mounting burden of bladder cancer. In March 2022, for example, the World Bladder Cancer Patient Coalition declared the 'Don't Go Red' theme for Bladder Cancer Awareness to raise awareness of warning signs and symptoms, underscoring the importance of early detection in enhancing long-term survival and quality of life. Furthermore, the global prevalence of bladder cancer is on the rise, with bladder cancer ranking among the top 10 high-incidence cancers worldwide according to the Global Cancer Observatory Statistics 2020. In the same report, it was noted that in 2020, there were an estimated 573,278 new cases of bladder cancer and 1,414,259 cases of prostate cancer worldwide. This high incidence of cancer globally is a significant driver for the market.
Bladder Cancer Therapeutics and Diagnostics Market- Key Insights
As per the analysis shared by our research analyst, the global Bladder Cancer Therapeutics and Diagnostics Market is estimated to grow annually at a CAGR of around 5.7% over the forecast period (2023-2030)
The Bladder Cancer Therapeutics and Diagnostics Market is projected to grow at a significant rate driven by increasing awareness of bladder diseases and available therapies, expanding healthcare expenditure, and the mounting burden of bladder cancer
Based on Diagnostic, the Cystoscopy segment was predicted to show maximum market share in the year 2022
Based on Cancer Type, Transitional Cell Bladder Cancer was the leading Segment in 2022
On the basis of region, North America was the leading revenue generator in 2022
Bladder Cancer Therapeutics and Diagnostics Market- Segmentation Analysis:
The Global Bladder Cancer Therapeutics and Diagnostics Market is segmented on the basis of Diagnostic, By Cancer Type, and Region.
Based on the Diagnostic, the market is divided into four segments: Cystoscopy, Bladder Ultrasound, Urinalysis, Other Diagnostics. The Cystoscopy segment generated the highest revenue, and it is expected to maintain its leading position throughout the forecast period. Cystoscopy, a procedure for visualizing the interior of the bladder and urethra using a specialized endoscope inserted through the urethra, is projected to be the dominant segment in the studied market during the forecast period. This cost-effective method is driven by increasing adoption, the rising prevalence of bladder cancer, and product launches by key market players.
The market is categorized by Cancer Type into three segments: Transitional Cell Bladder Cancer, Squamous Cell Bladder Cancer, Other Cancer Types. The transitional cell bladder cancer segment is expected to hold a significant share of the global bladder cancer diagnostics market by 2030, primarily due to the high incidence of transitional cell bladder cancer.
Bladder Cancer Therapeutics and Diagnostics Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period owing to the rising prevalence of cancer. For instance, as to the January 2022 estimates from the American Cancer Society, about 81,180 new cases of bladder cancer would occur in the United States year 2022, with 61,700 cases in men and 19,480 cases in women.
Bladder Cancer Therapeutics and Diagnostics Market- Competitive Landscape:
In the realm of bladder cancer therapeutics and diagnostics, companies are fervently researching and developing innovative approaches. In therapeutics, a notable focus is on the advancement of targeted therapies, particularly immunotherapies, to enhance bladder cancer treatment outcomes. Immune checkpoint inhibitors, exemplified by drugs like pembrolizumab and atezolizumab, have secured approvals for specific bladder cancer types, and ongoing investigations are expanding the repertoire of treatment options. Moreover, companies are dedicated to exploring novel biomarkers that can aid in early detection, prognosis, and treatment response assessment. These biomarkers can help refine diagnostic methods and guide more personalized therapeutic interventions, potentially improving patient outcomes and reducing the overall burden of bladder cancer. Companies in this space are committed to addressing the challenges associated with bladder cancer comprehensively, from early diagnosis to innovative treatment modalities, with the ultimate goal of enhancing patient care and survival rates.
Recent Developments:
In July 2022, the United States Food and Cancer Type Administration (FDA) agreed to review ImmunityBio's Biologics License Diagnostic (BLA) for N-803, which could benefit patients with or without Ta or T1 illness who have non-muscle-invasive bladder cancer (NMIBC) carcinoma in situ (CIS).
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BLADDER CANCER THERAPEUTICS AND DIAGNOSTICS MARKET KEY PLAYERS
- AstraZeneca
- Bristol-Myers Squibb Company
- Lilly
- F. Hoffmann-La Roche Ltd
- GSK plc
- Novartis AG
- Pfizer Inc.
- Sanofi
- Endo Pharmaceuticals Inc.
- Johnson & Johnson Services
GLOBAL BLADDER CANCER THERAPEUTICS AND DIAGNOSTICS MARKET, BY DIAGNOSTIC
- Cystoscopy
- Bladder Ultrasound
- Urinalysis
- Other Diagnostics
GLOBAL BLADDER CANCER THERAPEUTICS AND DIAGNOSTICS MARKET, BY CANCER TYPE
- Transitional Cell Bladder Cancer
- Squamous Cell Bladder Cancer
- Other Cancer Types
GLOBAL BLADDER CANCER THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV2204
Table of Contents
1. Bladder Cancer Therapeutics and Diagnostics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Bladder Cancer Therapeutics and Diagnostics Market Snippet by Diagnostics
- 2.1.2. Bladder Cancer Therapeutics and Diagnostics Market Snippet by Cancer Type
- 2.1.3. Bladder Cancer Therapeutics and Diagnostics Market Snippet by Country
- 2.1.4. Bladder Cancer Therapeutics and Diagnostics Market Snippet by Region
- 2.2. Competitive Insights
3. Bladder Cancer Therapeutics and Diagnostics Key Market Trends
- 3.1. Bladder Cancer Therapeutics and Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Bladder Cancer Therapeutics and Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Bladder Cancer Therapeutics and Diagnostics Market Opportunities
- 3.4. Bladder Cancer Therapeutics and Diagnostics Market Future Trends
4. Bladder Cancer Therapeutics and Diagnostics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Bladder Cancer Therapeutics and Diagnostics Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Bladder Cancer Therapeutics and Diagnostics Market Landscape
- 6.1. Bladder Cancer Therapeutics and Diagnostics Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Bladder Cancer Therapeutics and Diagnostics Market - By Diagnostics
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Diagnostics, 2022 & 2030 (%)
- 7.1.2. Cystoscopy
- 7.1.3. Bladder Ultrasound
- 7.1.4. Urinalysis
- 7.1.5. Other Diagnostics
8. Bladder Cancer Therapeutics and Diagnostics Market - By Cancer Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Cancer Type, 2022 & 2030 (%)
- 8.1.2. Transitional Cell Bladder Cancer
- 8.1.3. Squamous Cell Bladder Cancer
- 8.1.4. Other Cancer Types
9. Bladder Cancer Therapeutics and Diagnostics Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Bladder Cancer Therapeutics and Diagnostics Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Bladder Cancer Therapeutics and Diagnostics Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Bladder Cancer Therapeutics and Diagnostics Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Bladder Cancer Therapeutics and Diagnostics Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Bladder Cancer Therapeutics and Diagnostics Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Bladder Cancer Therapeutics and Diagnostics Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. AstraZeneca
- 10.2.2. Bristol-Myers Squibb Company
- 10.2.3. Lilly
- 10.2.4. F. Hoffmann-La Roche Ltd
- 10.2.5. GSK plc
- 10.2.6. Novartis AG
- 10.2.7. Pfizer Inc.
- 10.2.8. Sanofi
- 10.2.9. Endo Pharmaceuticals Inc.
- 10.2.10. Johnson & Johnson Services
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us
Product Code: ANV2204
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Bladder Cancer Therapeutics and Diagnostics Market: Diagnostics Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Diagnostics
- TABLE Global Bladder Cancer Therapeutics and Diagnostics Market, by Diagnostics 2018-2030 (USD Million)
- TABLE Bladder Cancer Therapeutics and Diagnostics Market: Cancer Type Snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Cancer Type
- TABLE Global Bladder Cancer Therapeutics and Diagnostics Market, by Cancer Type 2018-2030 (USD Million)
- TABLE Bladder Cancer Therapeutics and Diagnostics Market: Regional snapshot (2022)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Bladder Cancer Therapeutics and Diagnostics Market, by Region 2018-2030 (USD Million)
- TABLE North America Bladder Cancer Therapeutics and Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE North America Bladder Cancer Therapeutics and Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE North America Bladder Cancer Therapeutics and Diagnostics Market, by Cancer Type, 2018-2030 (USD Million)
- TABLE Europe Bladder Cancer Therapeutics and Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE Europe Bladder Cancer Therapeutics and Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE Europe Bladder Cancer Therapeutics and Diagnostics Market, by Cancer Type, 2018-2030 (USD Million)
- TABLE Asia Pacific Bladder Cancer Therapeutics and Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE Asia Pacific Bladder Cancer Therapeutics and Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE Asia Pacific Bladder Cancer Therapeutics and Diagnostics Market, by Cancer Type, 2018-2030 (USD Million)
- TABLE Latin America Bladder Cancer Therapeutics and Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE Latin America Bladder Cancer Therapeutics and Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE Latin America Bladder Cancer Therapeutics and Diagnostics Market, by Cancer Type, 2018-2030 (USD Million)
- TABLE Middle East and Africa Bladder Cancer Therapeutics and Diagnostics Market, by Country, 2018-2030 (USD Million)
- TABLE Middle East and Africa Bladder Cancer Therapeutics and Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
- TABLE Middle East and Africa Bladder Cancer Therapeutics and Diagnostics Market, by Cancer Type, 2018-2030 (USD Million)
List of Figures
- FIGURE Bladder Cancer Therapeutics and Diagnostics Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2022
- FIGURE Diagnostics segment market share analysis, 2022 & 2030
- FIGURE Diagnostics segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Cancer Type segment market share analysis, 2022 & 2030
- FIGURE Cancer Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Regional segment market share analysis, 2022 & 2030
- FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE North America Bladder Cancer Therapeutics and Diagnostics Market share and leading players, 2022
- FIGURE Europe Bladder Cancer Therapeutics and Diagnostics Market share and leading players, 2022
- FIGURE Asia Pacific Bladder Cancer Therapeutics and Diagnostics Market share and leading players, 2022
- FIGURE Latin America Bladder Cancer Therapeutics and Diagnostics Market share and leading players, 2022
- FIGURE Middle East and Africa Bladder Cancer Therapeutics and Diagnostics Market share and leading players, 2022
- FIGURE North America market share analysis by country, 2022
- FIGURE U.S. Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Canada Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Europe Bladder Cancer Therapeutics and Diagnostics Market share analysis by country, 2022
- FIGURE Germany Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Spain Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Italy Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE France Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE UK Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Russia Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Netherlands Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Sweden Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Poland Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of the Europe Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Asia Pacific Bladder Cancer Therapeutics and Diagnostics Market share analysis by country, 2022
- FIGURE India Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE China Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Japan Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE South Korea Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Australia Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Thailand Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Indonesia Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Phillipines Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of APAC Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Latin America Bladder Cancer Therapeutics and Diagnostics Market share analysis by country, 2022
- FIGURE Brazil Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Mexico Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Argentina Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Colombia Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of LATAM Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Middle East and Africa Bladder Cancer Therapeutics and Diagnostics Market share analysis by country, 2022
- FIGURE Saudi Arabia Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE United Arab Emirates Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Israel Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Turkey Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Algeria Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Egypt Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
- FIGURE Rest of MEA Bladder Cancer Therapeutics and Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.